View Post

Modified drug combination may reduce risk of recurrence for some breast cancer patients

In In The News by Barbara Jacoby

By: Virginia Commonwealth University From: Oncologists at VCU Massey Cancer Center were invited to co-author an editorial published in the Journal of Clinical Oncology providing expert commentary on findings from a large study conducted by German investigators that a modified drug combination may lead to a decreased chance of disease recurrence for women with high risk, HER-2 negative breast …